SEC Form 4 · accession 0000914190-16-000762
BIO-TECHNE Corp · TECH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Norman David Eansor
Officer — SVP - Biotech
Period of report
Aug 18, 2016
Accepted (ET)
Aug 22, 2016 · 5:12 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000842023
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | holding | — | — | — | 3,936 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F6 | $106.59 | Aug 18, 2016 | A | 18,819 | A | — | Aug 18, 2023 | Common Stock | 18,819 | 18,819 | D |
| Stock Option (Right to Buy)F7 | $106.59 | Aug 18, 2016 | A | 14,114 | A | — | Aug 18, 2023 | Common Stock | 14,114 | 14,114 | D |
| Restricted Stock UnitsF5,F7 | — | Aug 18, 2016 | A | 2,287 | A | — | — | Common Stock | 2,287 | 2,287 | D |
| Stock Option (Right to Buy)F2 | $94.35 | holding | — | — | — | — | Aug 12, 2021 | Common Stock | 15,000 | 15,000 | D |
| Stock Option (Right to Buy)F3 | $108.49 | holding | — | — | — | — | Aug 7, 2022 | Common Stock | 12,500 | 12,500 | D |
| Stock Option (Right to Buy)F4 | $108.49 | holding | — | — | — | — | Aug 7, 2022 | Common Stock | 9,375 | 9,375 | D |
| Restricted Stock UnitsF5,F4 | — | holding | — | — | — | — | — | Common Stock | 1,500 | 1,500 | D |
Explanation of responses
- F1Includes 1,666 shares of restricted stock units that vest on 7/1/17.
- F23,750 shares vest on each of 8/12/15, 8/12/16, 8/12/17 and 8/12/18.
- F33,125 shares vest on each of 8/7/16, 8/7/17, 8/7/18 and 8/7/19.
- F4Vests in full or in part on 8/7/18 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
- F5Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
- F6Vests 4,705 shares on each of 8/18/17, 8/18/18, and 8/18/19 and 4,704 shares on 8/18/20.
- F7Vests in full or in part on 8/18/19 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).